HPLC-MS/MS-Mediated Analysis of the Pharmacokinetics, Bioavailability, and Tissue Distribution of Schisandrol B in Rats

Figure 3

Mean plasma concentration-time curves for Schisandrol B following the intravenous administration of 2 mg/kg of monomer (a), the intragastric administration of 10 mg/kg monomer (b), and the intragastric administration of 6 mL/kg SCE (equivalent to 15 mg/kg of Schisandrol B monomer) (c).

(a)

(b)

(c)